Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

OpenNIH

NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)

$74,500,000
Total funding
Sep 18, 2026
Closes
View opportunity →
OpenNIH

NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)

$73,000,000
Total funding
Sep 18, 2026
Closes
View opportunity →
OpenNIH

NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)

$73,000,000
Total funding
Sep 18, 2026
Closes
View opportunity →
OpenNIH

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

$4,520,000
Total funding
Sep 24, 2026
Closes
View opportunity →
OpenNIH

Metastasis Research Network (U54 Clinical Trial Not Allowed)

$6,800,000
Total funding
Sep 25, 2026
Closes
View opportunity →
OpenNIH

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

NHLBI Program Project Applications (P01 Clinical Trials Optional)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)

Sep 25, 2026
Closes
View opportunity →